EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer (Q79294407)
Jump to navigation
Jump to search
scientific article published on 23 October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer |
scientific article published on 23 October 2006 |
Statements
EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer (English)
L Boerrigter
H Ruijter
I Tielen
D de Jong
P Baas
S Burgers
23 October 2006